1.4600
+0.0300
+(2.10%)
At close: April 17 at 4:00:02 PM EDT
1.4599
-0.00
(-0.01%)
After hours: April 17 at 7:41:56 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-118,006
-118,006
-121,142
-116,309
-106,110
Investing Cash Flow
-218,797
-218,797
70,703
58,443
-88,236
Financing Cash Flow
161,206
161,206
135,524
122,908
1,795
End Cash Position
50,530
50,530
226,142
141,052
76,009
Income Tax Paid Supplemental Data
4,893
4,893
--
--
--
Capital Expenditure
-15
-15
-193
-6,526
-1,654
Issuance of Capital Stock
161,871
161,871
135,510
130,476
--
Free Cash Flow
-118,021
-118,021
-121,335
-122,835
-107,764
12/31/2021 - 7/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANAB AnaptysBio, Inc.
20.55
+7.82%
RGNX REGENXBIO Inc.
5.94
-3.57%
FDMT 4D Molecular Therapeutics, Inc.
3.0600
+5.15%
APLT Applied Therapeutics, Inc.
0.3330
+9.61%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
CADL Candel Therapeutics, Inc.
4.5700
+0.88%
NKTX Nkarta, Inc.
1.8100
+3.43%
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
ABEO Abeona Therapeutics Inc.
4.8400
-0.21%
DAWN Day One Biopharmaceuticals, Inc.
6.84
+1.18%